Delineating the role of cooperativity in the design of potent PROTACs for BTK

Adelajda Zorba(Pfizer (United States)), Chuong Nguyen(Pfizer (United States)), Yingrong Xu(Pfizer (United States)), Jeremy T. Starr(Pfizer (United States)), Kris A. Borzilleri(Pfizer (United States)), James F. Smith(Pfizer (United States)), Hongyao Zhu(Pfizer (United States)), Kathleen A. Farley(Pfizer (United States)), Weidong Ding(Pfizer (United States)), James Schiemer(Pfizer (United States)), Xidong Feng(Pfizer (United States)), Jeanne S. Chang(Pfizer (United States)), Daniel P. Uccello(Pfizer (United States)), Jennifer A. Young(Pfizer (United States)), Carmen N. Garcia-Irrizary(Pfizer (United States)), Lara C. Czabaniuk(Pfizer (United States)), Brandon P. Schuff(Pfizer (United States)), Robert M. Oliver(Pfizer (United States)), Justin I. Montgomery(Pfizer (United States)), Matthew M. Hayward(Pfizer (United States)), Jotham W. Coe(Pfizer (United States)), Jinshan Chen(Pfizer (United States)), Mark Niosi(Pfizer (United States)), Suman Luthra(Pfizer (United States)), Jaymin C. Shah(Pfizer (United States)), Ayman El‐Kattan(Pfizer (United States)), Xiayang Qiu(Pfizer (United States)), Graham M. West(Pfizer (United States)), Mark C. Noe(Pfizer (United States)), Veerabahu Shanmugasundaram(Pfizer (United States)), A. Gilbert(Pfizer (United States)), Matthew F. Brown(Pfizer (United States)), Matthew F. Calabrese(Pfizer (United States))
Proceedings of the National Academy of Sciences
July 16, 2018
Cited by 420Open Access
Full Text

Abstract

Proteolysis targeting chimeras (PROTACs) are heterobifunctional small molecules that simultaneously bind to a target protein and an E3 ligase, thereby leading to ubiquitination and subsequent degradation of the target. They present an exciting opportunity to modulate proteins in a manner independent of enzymatic or signaling activity. As such, they have recently emerged as an attractive mechanism to explore previously "undruggable" targets. Despite this interest, fundamental questions remain regarding the parameters most critical for achieving potency and selectivity. Here we employ a series of biochemical and cellular techniques to investigate requirements for efficient knockdown of Bruton's tyrosine kinase (BTK), a nonreceptor tyrosine kinase essential for B cell maturation. Members of an 11-compound PROTAC library were investigated for their ability to form binary and ternary complexes with BTK and cereblon (CRBN, an E3 ligase component). Results were extended to measure effects on BTK-CRBN cooperative interactions as well as in vitro and in vivo BTK degradation. Our data show that alleviation of steric clashes between BTK and CRBN by modulating PROTAC linker length within this chemical series allows potent BTK degradation in the absence of thermodynamic cooperativity.


Related Papers

No related papers found

Powered by citation graph analysis